Mehmet Erkan Dogan (Mehmet Erkan Doğan)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 5

Top Topics

Percutaneous Coronary Intervention

Systematic Review

Cataract Surgery

Optical Coherence Tomography

Top Venues

Diagnostics (Basel, Switzerland)

Ocular immunology and inflammation

Journal of ophthalmology

International ophthalmology

Akdeniz University Hospital

Akdeniz Üniversitesi Hastanesi (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Akdeniz University Hospital Aug 01 2018

Turkey

specialist :: opthalmology

Elmali state hospital Nov 17 2014 - Jul 31 2018

Turkey

opthalmology specialist :: opthalmology

Education History

Akdeniz Üniversitesi Hastanesi Sep 01 2002 - Jun 16 2009

Turkey

PHD

Publications

Melih Akıdan, Muhammet Kazim Erol, Birumut Gedik, Mehmet Erkan Dogan, İbrahim Başol, Elçin Süren
Changes in Outcomes of Macular Optical Coherence Tomography Angiography Following Surgery for Optic Disc Pit Maculopathy. Diagnostics (Basel, Switzerland) 14 (9) (2024)
Melih Akıdan, Muhammet Kazim Erol, Birumut Gedik, Mehmet Erkan Dogan, İbrahim Başol, Elçin Süren
Changes in Outcomes of Macular Optical Coherence Tomography Angiography Following Surgery for Optic Disc Pit Maculopathy. Diagnostics (Basel, Switzerland) 14 (9) (2024)
Yusuf Ayaz, Çisil Erkan Pota, İbrahim Başol, Mehmet Erkan Dogan, Elif Betül Türkoğlu Şen, Mustafa Ünal
Anterior segment complications after dexamethasone implantations:real world data. International ophthalmology (2023)
Elçin Süren, Mustafa Kalaycı, Ersan Cetinkaya, Mehmet Fatih Kucuk, Mehmet Erkan Dogan, Doğan Durmaz, Fulya Duman, Muhammet Kazim Erol
Evaluation of the Findings of Patients Who Underwent Sutureless Flanged Transconjunctival Intrascleral Intraocular Lens Implantation with or without Pars Plana Vitrectomy. Journal of ophthalmology 2021 (2021)
Ahmet Burak Bilgin, Mehmet Erkan Dogan, Yusuf Ayaz, Kadri Cemil Apaydin
Comparison of Efficacy and Safety of Loteprednol Etabonate 0.5% and Topical Dexamethasone 1% in Post-Vitrectomy Inflammation. Ocular immunology and inflammation 27 (2) (2017)